Trading in subscription rights and BTAs in Acarix' rights issue has been delayed, due to
late submission of the application to Nasdaq.
This situation is beyond Acarix control.
Trading will commence tomorrow, October 10. All other information in the press release
about Acarix rights issue, published earlier today is confirmed as accurate.
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.